Gene: COLGALT2
Official Full Name: collagen beta(1-O)galactosyltransferase 2provided by HGNC
Gene Summary: Predicted to enable procollagen galactosyltransferase activity. Predicted to be involved in collagen fibril organization. Predicted to be located in endoplasmic reticulum lumen. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29830 | COLGALT2 Knockout cell line (HEK293) | Human | COLGALT2 | 1:3~1:6 | Negative | Online Inquiry |
COLGALT2 Gene Knockout Cell Lines represent a breakthrough in genomic studies, specifically designed to facilitate the exploration of gene function and disease mechanisms associated with collagen type VI synthesis. These cell lines are engineered to exhibit a complete knockout of the COLGALT2 gene, which is crucial for the proper assembly of collagen and extracellular matrix structures. By utilizing CRISPR-Cas9 technology, these cell lines allow researchers to study the biological impacts of COLGALT2 deficiency in a controlled environment, providing insights into connective tissue disorders and various pathologies related to collagen abnormalities.
The primary mechanism of action for these knockout cell lines involves the disruption of the COLGALT2 gene expression, which leads to alterations in collagen production and matrix organization. This functional impairment serves as a valuable model for analyzing fundamental biological processes such as cell adhesion, migration, and tissue integrity. By applying these knockout models, researchers can investigate the correlations between COLGALT2 dysfunction and diseases, ranging from osteogenesis imperfecta to various forms of muscular dystrophy.
Scientifically, the importance of COLGALT2 Gene Knockout Cell Lines lies in their ability to provide an in-depth understanding of gene-to-phenotype relationships within the context of human health. Their application spans numerous domains, from fundamental biology to translational research, allowing investigators to unravel the complexities of collagen-related diseases and identify potential therapeutic targets.
When comparing COLGALT2 Gene Knockout Cell Lines to traditional models, such as wild-type or transient knockdown systems, the permanent gene knockout provides greater stability and reproducibility of results. This feature enhances the reliability of experimental outcomes and reduces variability associated with transient techniques. Additionally, designed specifically for studying the collagen nexus in pathological processes, these cell lines surpass generic cell models by offering a more relevant biological context.
For researchers and clinicians engaged in the fields of molecular biology, genetics, and regenerative medicine, COLGALT2 Gene Knockout Cell Lines are invaluable tools that enable profound advancements in our understanding of collagen physiology and pathology. Our commitment to high-quality biological products ensures that you receive the most reliable and cutting-edge solutions to propel your research forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.